GlassScriptPhysician profile
Imran Ahmad
NPI 1841722717
$31,553.81
in general payments reported to CMS, 2019-2025
8 companies · $4,250 in 2025
The $4,250 reported for 2025 was more than what 87% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $27.74 · 2023: $23K · 2024: $4,174 · 2025: $4,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Travel and Lodging: $7,273 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $1,718 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,025.75 |
| Travel and Lodging | $7,273.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $1,718.28 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,753.97 | 2023-2025 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| Davol INC. | $1,505.01 | 2024-2025 | Phasix Mesh |
| Baxter Healthcare | $104.16 | 2024 | Perclot |
| Boston Scientific Corporation | $90.10 | 2023 | Resolution 360 Clip |
| Braintree Laboratories, INC. | $33.57 | 2024-2025 | Suflave, Sutab |
| Abbvie INC. | $27.74 | 2022 | |
| Genentech USA, INC. | $20.94 | 2025 | Tecentriq |
| Ethicon US, LLC | $18.32 | 2025 | Echelon; Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.